For years, OHSU has been on the front lines in attacking MS. Now, thanks to innovative “high-risk” research funded by philanthropy, a breakthrough drug that could stimulate critical myelin repair will start clinical trials within a year, raising expectations of MS patients worldwide. Hear the powerful story of the doctor who wouldn’t give up, and a grateful patient who has new hope thanks to research her family has generously supported.

This video was shared by Oregon Health & Science University (OHSU).